Keratinocyte differentiation
Keratinocyte differentiation is the programme that produces the skin barrier. A committed basal cell undergoes a precisely sequenced molecular cascade over 40–60 days, activating differentiation genes in a calcium-dependent, PKC/AP-1-mediated order that generates – in parallel – the cornified envelope, the intercellular lipid triad, filaggrin-derived NMF, and lamellar body-delivered antimicrobial peptides. Every barrier entity in this knowledge base describes one output of this programme. Programme completeness determines all five outputs simultaneously: partial execution does not degrade one output in isolation. In ageing, efficiency declines at multiple molecular nodes – NHE1 decline reduces calcium signal precision at the SG, PGC-1α reduction impairs the energy supply terminal differentiation demands, and S100A7 loss shifts the differentiation-autophagy balance. Treatments that restore programme efficiency – PPARα activation, IL-4/ IL-13 resolution, stimulating professional treatments – address all five barrier outputs from the same upstream intervention.
The skin barrier is not assembled from ingredients applied to the surface. It is manufactured from inside by a cellular programme running continuously from the stratum basale to the stratum corneum surface. Keratinocyte differentiation is that programme – the coordinated, irreversible molecular cascade that transforms a proliferating basal cell into a structurally complete corneocyte whilst producing, at precisely timed stages along the way, every component the functional barrier requires. What makes it clinically relevant is not simply that the programme exists but that its completeness is variable. In healthy young skin it runs at full capacity and produces all five barrier outputs – structural protein scaffold, cornified envelope, intercellular lipid triad, NMF and acid mantle contributions, antimicrobial peptides – in the correct proportions and at the correct layer. In aged, inflamed, or metabolically compromised skin, the programme runs in a degraded state that reduces all five outputs simultaneously, from the same upstream failure, regardless of how much substrate is supplemented topically. Understanding the programme is the prerequisite for understanding why single-target interventions so consistently underperform. [1]
The commitment switch
Before differentiation can begin, a basal keratinocyte must make an irreversible decision: stay and continue dividing, or commit to the differentiation journey. This decision is controlled by the p63–p21 axis.
In the stratum basale, the transcription factor ΔNp63α maintains the proliferative state by repressing p21 expression and sustaining MYC-driven growth networks. p63 is the “stay” signal. The differentiation commitment trigger – rising intracellular calcium via CaSR activation as the cell begins moving upward – activates PKC (protein kinase C) isoforms through a calcium-dependent pathway. PKC activation drives AP-1 (activator protein-1) complex formation and binding at calcium/phorbol ester response elements in differentiation gene promoters, initiating the differentiation transcriptional programme. Simultaneously, PKC/MAPK signalling drives expression of the miR-17 microRNA family, which targets and suppresses p63 mRNA. As p63 falls, its repression of p21 is released: p21 rises, inhibits cyclin-dependent kinases, imposes RB-dependent cell cycle exit, and commits the cell to differentiation. [7] This is the point of no return – the cell cannot re-enter the cell cycle from this position, and the entire downstream programme becomes self-sustaining as it moves into progressively higher calcium territory.
Sequential gene expression: the programme’s architecture
The differentiation programme does not activate all genes simultaneously. It unfolds in a defined sequence, with each wave of expression dependent on the calcium concentration and signalling context of the layer the cell currently occupies. The sequential order is confirmed across multiple systems. [6]
| Stage | Layer | Key molecules expressed | Function in programme |
|---|---|---|---|
| Early differentiation | Basal–spinous transition | K1, K10 (replace K5/K14) | Structural reinforcement; spinous layer architecture |
| Mid differentiation | Spinous–lower granular | Involucrin, envoplakin, transglutaminase-1 (TGM1), SPRRs | Cornified envelope scaffold construction; TGM1 crosslinking capacity |
| Late differentiation | Upper granular | Loricrin, LEKTI (SPINK5), KLK5, KLK7 | Major CE protein (~70% mass); desquamation enzyme and inhibitor co-delivery |
| Terminal differentiation | SG–SC interface | Profilaggrin → filaggrin; caspase-14; lamellar body exocytosis | Keratin compaction; NMF generation; ceramide precursor delivery; cornification |
| Cornification | SC formation | Corneodesmosin, loricrin crosslinking, lipid envelope attachment | Corneocyte structural completion; barrier lipid bilayer establishment |
The sequential dependency matters clinically. K1/K10 expression at the spinous layer is a prerequisite for the structural context in which mid-differentiation events occur. Loricrin expression at the late granular stage is a prerequisite for the cornified envelope that terminal-stage filaggrin processing and lamellar body secretion complete. A programme that is disrupted at any stage does not simply delay subsequent stages – it produces structurally abnormal outputs at every stage downstream of the disruption point. [1]
The Epidermal Differentiation Complex (EDC) on chromosome 1q21 contains the majority of these differentiation genes in a single locus, with chromatin remodelling by SATB1 and BRG1 coordinating their sequential opening and expression as calcium signals progress. The EDC is not simply a gene cluster – it is a physically co-regulated programme whose chromatin state reflects differentiation stage. Epigenetic dysregulation of the EDC in inflammatory conditions partially explains why cytokine-driven barrier impairment is broader than individual gene suppression would predict. [3]
The five barrier outputs
Every entity in the barrier biology cluster of this knowledge base describes one output of the differentiation programme. Naming them together establishes why programme completeness determines all of them at once:
1. Cornified envelope – involucrin and loricrin crosslinked by TGM1, with ceramides attached to the CE outer surface by TGM1 in the terminal stage. Structural integrity of the corneocyte depends on programme completeness through the entire mid-to-terminal phase.
2. Keratin scaffold – K1/K10 initiated at the spinous stage, providing the mechanical architecture that subsequent layers build upon. Disruption at this stage produces fragile spinous cells that impair the structural context for all subsequent differentiation events.
3. Barrier lipid triad – ceramides, free fatty acids, and cholesterol synthesised in the SG via PPARα-driven gene activation, packaged into lamellar bodies, and secreted at the SG–SC interface. The lipid triad is a product of the terminal differentiation stage, not an independent parallel synthesis event. PPARα is activated by calcium-responsive signalling in the differentiating SG cell – the lipid synthesis and the terminal differentiation stage are co-regulated.
4. Filaggrin-derived NMF and acid mantle contribution – profilaggrin processed into filaggrin monomers in the SC, then further degraded into NMF components ( pyrrolidone carboxylic acid, urocanic acid, and free amino acids). This processing is calcium-dependent at both the profilaggrin cleavage step and the downstream enzymatic steps. The NMF-derived acids are the passive acidification contribution to the acid mantle – available only if the terminal differentiation stage produced adequate profilaggrin to begin with.
5. Antimicrobial peptide delivery – hBD-2, hBD-3, and cathelicidin (hCAP-18/LL-37 precursor) co-packaged in lamellar bodies alongside ceramide precursors and processing enzymes. Their delivery is co-incident with lamellar body exocytosis at the terminal differentiation stage. Lamellar body secretion defects impair antimicrobial delivery and barrier lipid delivery simultaneously. [5]
Programme efficiency in ageing
Ageing does not simply slow keratinocyte turnover. It reduces programme efficiency at multiple molecular nodes simultaneously, producing lower-quality outputs from the same cell input. Three independent mechanisms compound:
NHE1 decline reduces calcium signal precision at the SG. NHE1 is necessary for calcium-induced differentiation in keratinocytes – blocking NHE1 directly inhibits calcium-driven PKC/AP-1 activation, confirming it is not a parallel event but a mechanistically required component of the differentiation calcium signal. NHE1 preferentially acidifies the SG extracellular domain, and its age-related decline reduces the precision of the calcium gradient at exactly the layer where the most calcium-dependent differentiation events occur: profilaggrin processing, lamellar body exocytosis, and cornification. The result is not simply an acid mantle deficit. It is a degraded differentiation signal at the most critical stage of the programme. [2]
PGC-1α decline reduces mitochondrial energy supply. Terminal differentiation is metabolically demanding – profilaggrin is the largest protein produced in the programme, cornified envelope crosslinking requires substantial TGM1 activity, and lamellar body biogenesis is an energy-intensive Golgi-lysosome trafficking operation. PGC-1α (peroxisome proliferator-activated receptor gamma coactivator 1-alpha) is the master regulator of mitochondrial biogenesis, and its expression measurably declines in aged skin. PGC-1α-deficient keratinocytes show reduced oxygen consumption rate and impaired terminal differentiation gene expression – including filaggrin and loricrin – confirming that the energy deficit directly limits programme completion rather than operating as a parallel ageing mechanism. In a reconstructed human epidermis model, C8-salicylic acid activation of PGC-1α restored both oxygen consumption and differentiation marker expression simultaneously. [4]
S100A7 decline alters the differentiation-autophagy-senescence balance. S100A7 (psoriasin) is a calcium-binding protein expressed in differentiating keratinocytes whose expression is markedly reduced in aged skin. A 2026 study confirmed that S100A7 knockdown produces transcriptional alterations across differentiation, autophagy, and senescence pathways simultaneously – not selectively impairing one output but shifting the overall programme state toward a senescence-like phenotype. S100A7 supplementation increased autophagy and attenuated senescence markers, suggesting it acts as a context-dependent stabiliser of the differentiation programme against the SASP environment that accumulates in aged tissue. [8]
The compound effect of these three mechanisms is a differentiation programme that is slower, less precise at its calcium-dependent terminal phase, less energetically supported, and more vulnerable to SASP interference – producing thinner cornified envelopes, incomplete lamellar body cargo, reduced NMF, and a weaker acid mantle contribution from a cell population that is turning over at approximately half the rate of young skin.
What impairs programme completeness
Several inflammatory and environmental inputs specifically impair programme completeness rather than simply damaging its outputs after the fact:
IL-4 and IL-13 suppress loricrin, involucrin, and filaggrin simultaneously via STAT6 – not filaggrin in isolation. The EDC chromatin remodelling programme is disrupted at the level of the entire complex, which is why atopic skin shows a global terminal differentiation deficit rather than a single protein deficiency. The programme is trying to run in a cytokine environment that is dismantling its transcriptional apparatus whilst it does so. See NF-κB and Filaggrin entities.
PPARα suppression reduces lamellar body formation, filaggrin, involucrin, and transglutaminase-1 expression together. PPARα is co-regulated with the terminal differentiation programme through the same calcium-responsive signalling pathways, meaning its Th2-mediated or age-related suppression degrades both the lipid synthesis and the structural protein outputs simultaneously. See PPARα entity.
Calcium gradient disruption – from hard water, alkaline cleansers, or vapour-impermeable occlusion – reduces CaSR activation precision at the most calcium-dependent stage of the programme. The commitment switch and mid-differentiation stages are less affected; the terminal stage, where the highest calcium concentrations are required, is disproportionately impaired. See Epidermal Calcium Gradient entity.
Cortisol independently suppresses profilaggrin expression and accelerates premature cornification, producing a programme that terminates early with structurally incomplete cornified envelopes. The HPA axis therefore contributes to differentiation impairment independently of the Th2 inflammatory route – relevant for clients presenting with stress-related barrier deterioration in the absence of atopic history. See HPA Axis entity.
Cellular senescence bystander effect – senescent keratinocytes produce SASP cytokines that impair adjacent non-senescent cell differentiation, propagating the differentiation deficit laterally through tissue without requiring direct senescence of every affected cell. See Cellular Senescence entity.
Clinical Application
The clinical significance of the programme frame lies in what it implies about intervention targeting. The standard approach to barrier dysfunction – topical ceramides for ceramide deficiency, NMF for dehydration, occlusive emollients for TEWL – addresses outputs of the programme downstream of wherever the programme has failed. It does not restore the programme.
This matters because programme failure reduces all five barrier outputs simultaneously. A client with Th2-driven IL-4/IL-13 signalling and consequent differentiation programme impairment does not only have low ceramides. She has reduced cornified envelope completeness, reduced lamellar body cargo loading, reduced NMF, impaired antimicrobial peptide delivery, and degraded desquamation enzyme production – from the same upstream STAT6-mediated EDC suppression. Topical ceramide supplementation addresses one output of this multi-output failure. It is appropriate as a supportive measure but insufficient as a primary intervention.
The upstream intervention logic follows directly:
Resolving the inflammatory block – reducing IL-4/IL-13 via CAP, polynucleotides, or dietary omega-3 – restores EDC chromatin accessibility and the terminal differentiation transcriptional programme, producing recovery across all five outputs from the same intervention.
PPARα activation – dietary EPA/DHA, topical oat lipid agonists, exosome-mediated PPARα restoration – restores both the lipid synthesis and the structural differentiation gene outputs co-regulated through PPARα, simultaneously improving ceramides, lamellar body secretion, filaggrin, and transglutaminase-1 activity.
Professional stimulating treatments – thulium fractional laser, microneedling, and exosome delivery – activate the terminal differentiation programme through distinct mechanisms (controlled epidermal injury, growth factor signalling, and direct PPARα/SPTLC1 gene restoration respectively), accelerating all five barrier outputs in parallel. The lipid metabolism gene upregulation documented in early thulium responders is not a ceramide synthesis event in isolation – it is a programme activation event with downstream effects across the full output profile.
For aged clients specifically, where programme efficiency is reduced at the NHE1, PGC-1α, and S100A7 nodes, supplementing outputs topically is even less sufficient as a primary strategy. The programme is producing less of everything because it is running less efficiently. The question is not which outputs to supplement, but which programme efficiency mechanisms can be addressed. NHE1 activation via rosmarinic acid, stimulating treatments that drive the differentiation cascade, and anti-inflammatory interventions that remove the SASP environment impairing adjacent cells each address one degraded node. Combining them is more rational than applying a richer ceramide formulation to a programme that cannot produce more ceramides regardless of precursor availability.
Clinical Pearl A client who presents with simultaneously rough texture, persistent dehydration, reactive sensitivity, and poor response to barrier repair products despite consistent use is describing the output signature of a degraded differentiation programme, not an accumulation of separate ingredient deficiencies. The diagnostic question is not “which barrier component is missing?” but “which programme inputs are failing?” – because the programme produces all the missing components from the same cascade. That reframe changes the treatment strategy completely: from supplementing outputs to restoring programme efficiency.
References
Abhishek S, Palamadai Krishnan S (2016). Epidermal Differentiation Complex: A Review on Its Epigenetic Regulation and Potential Drug Targets. Cell J, 18(1), 1-6 . doi.org/10.22074/cellj.2016.3980
Adams MP, Mallet DG, Pettet GJ (2015). Towards a quantitative theory of epidermal calcium profile formation in unwounded skin. PLoS One, 10(1), e0116751 . doi.org/10.1371/journal.pone.0116751
Leśniak W (2024). Dynamics and Epigenetics of the Epidermal Differentiation Complex. Epigenomes, 8(1) . doi.org/10.3390/epigenomes8010009
Luo Y, Bollag WB (2024). The Role of PGC-1α in Aging Skin Barrier Function. Cells, 13(13) . doi.org/10.3390/cells13131135
Marenholz I, Zirra M, Fischer DF, et al. (2001). Identification of human epidermal differentiation complex (EDC)-encoded genes by subtractive hybridization of entire YACs to a gridded keratinocyte cDNA library. Genome Res, 11(3), 341-55 . doi.org/10.1101/gr.114801
Marshall D, Hardman MJ, Nield KM, et al. (2001). Differentially expressed late constituents of the epidermal cornified envelope. Proc Natl Acad Sci U S A, 98(23), 13031-6 . doi.org/10.1073/pnas.231489198
McDade SS, Patel D, McCance DJ (2011). p63 maintains keratinocyte proliferative capacity through regulation of Skp2-p130 levels. J Cell Sci, 124(Pt 10), 1635-43 . doi.org/10.1242/jcs.084723
Peng G, Hattori F, Ogawa H, et al. (2026). Decreased S100A7 expression is linked to altered differentiation-, autophagy- and senescence-related programs during skin aging. NPJ Aging, 12(1), 31 . doi.org/10.1038/s41514-026-00330-8
Also Known As
- keratinocyte cell differentiation
- keratinocyte terminal differentiation
- terminal differentiation
Learn More
This topic is discussed in 2 articles:
-

The programmed developmental sequence by which basal keratinocytes progressively mature through the spinous, granular, and cornified layers to become corneocytes. At the stratum granulosum stage, the process includes filaggrin expression, lamellar body secretion, cornified envelope formation, and eventual loss of nucleus. This cascade produces both the corneocyte scaffold and the lipid barrier of the stratum corneum. Regulated by the epidermal calcium gradient, and includes the acidification pathways that decline with age (notably NHE1 expression).
-

The coordinated, one-way molecular programme by which a basal keratinocyte progresses through the epidermal layers to produce the structural and biochemical components of the skin barrier.
-

The coordinated, one-way molecular programme by which a basal keratinocyte progresses through the epidermal layers to produce the structural and biochemical components of the skin barrier.